BIAL PORTELA & Cª S A has a total of 44 patent applications. It decreased the IP activity by 58.0%. Its first patent ever was published in 2009. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Mexico. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are IVAX GYOGYSZERKI KFT, SHANGHAI CHEMEXPLORER CO LTD and BINDER DIETER.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 9 | |
#2 | EPO (European Patent Office) | 7 | |
#3 | Mexico | 5 | |
#4 | United States | 5 | |
#5 | Australia | 3 | |
#6 | Brazil | 3 | |
#7 | Singapore | 3 | |
#8 | Chile | 2 | |
#9 | Colombia | 2 | |
#10 | Serbia | 2 | |
#11 | Canada | 1 | |
#12 | India | 1 | |
#13 | Ukraine | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology |
# | Name | Total Patents |
---|---|---|
#1 | Kiss Laszlo Erno | 26 |
#2 | Rossi Tino | 19 |
#3 | Beliaev Alexander | 19 |
#4 | Soares Da Silva Patrício | 14 |
#5 | Leal Palma Pedro Nuno | 14 |
#6 | Pinto Rui | 9 |
#7 | Wahnon Jorge Bruno Reis | 5 |
#8 | Rosa Carla Patrícia Da Costa Pereira | 5 |
#9 | Cardona Francisco | 5 |
#10 | Laszlo Erno Kiss | 5 |
Publication | Filing date | Title |
---|---|---|
SG11202004231YA | Dopamine-β-hydroxylase inhibitors | |
AU2017330175A1 | Dopamine-β-hydroxylase inhibitors | |
US2015197503A1 | Process for the synthesis of substituted urea compounds |